Dexamethasone Not Favored for Chronic Subdural Hematoma
Dexamethasone worse than placebo with respect to favorable outcome at six months
New Mammogram-Based Measures Improve Breast Cancer Prediction
For screen-detected, younger-diagnosis breast cancers, best-fitting models include new measures based on brightness, texture
E-Cigarettes as Consumer Devices May Not Improve Smoking Cessation
In randomized clinical trials, e-cigarette use linked to more quitting for smokers provided e-cigarettes versus conventional therapy
Oral Azacitidine Benefits Some Older Adults With AML
Overall, relapse-free survival prolonged among older patients in first remission after chemo who receive CC-486 versus placebo
Head and Neck Cancer Surgery Seems Safe During COVID-19
Links seen for severe pulmonary complications in COVID-19-positive patients with advanced tumor stage, critical care admission
Inequities Seen in Accessing Telemedicine During COVID-19
Factors linked to fewer completed telemedicine visits include older age, Asian race, non-English as preferred language, Medicaid insurance
SARS-CoV-2 Infection Rate Low in Patients Receiving Antitumor Therapy
Less than 1 percent of patients receiving antitumor treatment between Jan. 15 and May 4, 2020, developed COVID-19
Incidence of Young-Onset Esophageal Adenocarcinoma Rising
Young-onset esophageal adenocarcinoma presenting at more advanced stages; proportion of advanced stage up from 1975 to 2015
Triple Treatment Combo Beneficial in BRAF-Mutant CRC
Irinotecan, cetuximab, and vemurafenib improve progression-free survival in BRAFV600E-mutated colorectal cancer
Privileged White U.S. Citizens Have Better Health Outcomes
However, outcomes are not always better than those of average citizens in 12 comparison countries
